Cowen And Company, LLC Amarin Corp Plcuk Call Options Transaction History

Cowen And Company, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $119,700 - $156,660	-42,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $90,720 - $145,040	-28,000 Reduced 40.0%	42,000 $2,000
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $275,800 - $408,800	70,000 New	70,000 $37,000
Q1 2021 May 04, 2021	SELL	$5.03 - $8.8 $163,475 - $286,000	-32,500 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$4.04 - $5.31 $22,220 - $29,204	5,500 Added 20.37%	32,500 $10,000
Q3 2020 Nov 03, 2020	BUY	$3.64 - $7.76 $16,380 - $34,920	4,500 Added 20.0%	27,000 $6,000
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $287,756 - $497,252	-60,200 Reduced 72.79%	22,500 $31,000
Q1 2020 May 11, 2020	BUY	$4.0 - $21.53 $231,200 - $1.24 Million	57,800 Added 232.13%	82,700 $1,000
Q4 2019 Feb 11, 2020	BUY	$13.94 - $24.12 $347,106 - $600,588	24,900 New	24,900 $13,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.